Ownership

Jeremy Bender - CHIEF EXECUTIVE OFFICER, Director at Day One Biopharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type: Individual
Role: CHIEF EXECUTIVE OFFICER, Director
Stock Symbol: DAWN on Nasdaq
Industry: Pharmaceutical Preparations
All Insider Reports: All Insider Reports

Jeremy Bender - trading volume in the past year for Day One Biopharmaceuticals, Inc.

	Shares	%	Avg Price	Total $
Buys
Sells	-116K	100%	$16.80	-$1.95M
Net	-116K	-100%		-$1.95M

Holdings reported by Jeremy Bender for Day One Biopharmaceuticals, Inc.

Class	Num Shares	Value	Price $	Transaction Date	Ownership	Underlying Class	Underlying Amount
Common Stock	807K	$10.7M	$13.21	Nov 15, 2024	Indirect
Restricted Stock Unit (RSU)	164K	$2.63M	$16.08	May 15, 2024	Direct	Common Stock
Restricted Stock Unit (RSU)	140K	$1.85M	$13.21	Nov 15, 2024	Direct	Common Stock
Common Stock	108K	$1.43M	$13.21	Nov 18, 2024	Direct
Stock Option (right to buy Common Stock)	286K			Jan 5, 2024	Direct	Common Stock

Transactions reported by Jeremy Bender for Day One Biopharmaceuticals, Inc.

Sym	Class	Transaction	%	Value $	* Price $	Shares	Shares After	Date	Ownership

* An asterisk sign (*) next to the price indicates that the price is likely invalid.